glp-1 and gas Glucagon-like peptide-1: Trends in Endocrinology

Understanding the specific characteristics of the pain, such as its intensity, quality, and any associated symptoms, can significantly aid in the diagnostic process

Nikoo M, Radnia H, Farokhnia M, Mohammadi MR, Akhondzadeh S

Long-term use is required for sustained weight loss

April 21, 2026: Parties Submit Status Report Ahead of Hearing in MDL Involving Lawsuits Over Zepbound, Other GLP-1s Dozens of people who took GLP-1 drugs, like Zepbound, have filed lawsuits, claiming they developed severe side effects that they were not warned about

The results showed that semaglutide users had a 40% to 70% lower risk of Alzheimers compared to those on other diabetes medications